Quick Takeaways
- Joseph C. Papa has 6 issuer positions tracked on this page.
- Estimated disclosed ownership value: $53,135,631.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Joseph C. Papa
- Location
- Gaithersburg, MD
- Summary
- The estimated net worth of Joseph C. Papa is at least $53,135,631 dollars as of 02 Apr 2026. Joseph C. Papa is the CEO & Chairman, Director of Bausch & Lomb Corp and owns shares of Bausch & Lomb Corp (BLCO) stock worth about $37.68M. Joseph C. Papa is the Director of Bausch Health Companies Inc. and owns shares of Bausch Health Companies Inc. (BHC) stock worth about $11.45M. Joseph C. Papa is the President and CEO, Director of Emergent BioSolutions Inc. and owns shares of Emergent BioSolutions Inc. (EBS) stock worth about $3.36M. Joseph C. Papa is the Director of Candel Therapeutics, Inc. and owns shares of Candel Therapeutics, Inc. (CADL) stock worth about $508K. Joseph C. Papa is the Director of Milestone Pharmaceuticals Inc. and owns shares of Milestone Pharmaceuticals Inc. (MIST) stock worth about $137K.
- Signature
- /s/ Charles Schoch, as Attorney-In-Fact for Joseph C. Papa
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Joseph C. Papa and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Bausch & Lomb Corp ($37,684,665).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Joseph C. Papa
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| BLCO | Bausch & Lomb Corp | CEO & Chairman, Director | $37,684,665 | 05 May 2022 | ||
| BHC | Bausch Health Companies Inc. | Director | $11,449,095 | 10 May 2022 | ||
| EBS | Emergent BioSolutions Inc. | President and CEO, Director | $3,356,840 | +$349,800 | +12% | 03 Mar 2026 |
| CADL | Candel Therapeutics, Inc. | Director | $508,031 | 31 Mar 2026 | ||
| MIST | Milestone Pharmaceuticals Inc. | Director | $137,000 | 11 Jul 2025 | ||
| RXDX | Prometheus Biosciences, Inc. | Director | 16 Jun 2023 |
Insider Transactions Reported by Joseph C. Papa:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.